MEDI 105-Novel purine derivatives as potent dual Src/Abl tyrosine kinase inhibitors

被引：0

作者：

Wang, Yihan ^{[1
]}

Shakespeare, William C. ^{[1
]}

Huang, Wei-sheng ^{[1
]}

Sundaramoorthi, Raji ^{[1
]}

Lentini, Scott ^{[1
]}

Das, Sasmita ^{[1
]}

Liu, Shuangying ^{[1
]}

Banda, Geeta ^{[1
]}

Wen, David ^{[1
]}

Zhu, Xiaotian ^{[1
]}

Xu, Qihong ^{[1
]}

Keats, Jeff ^{[1
]}

Wang, Frank ^{[1
]}

Wardwell, Scott ^{[1
]}

Ning, Yaoyu ^{[1
]}

Snodgrass, Joseph T. ^{[1
]}

Broudy, Mark I. ^{[1
]}

Russian, Karin ^{[1
]}

Iulucci, John ^{[1
]}

Dalgarno, David ^{[1
]}

Clackson, Tim ^{[1
]}

Sawyer, Tomi K. ^{[1
]}

机构：

[1] ARIAD Pharmaceut Inc, Cambridge, MA 02139 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2008年 / 236卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

105-MEDI

引用

页数：1

共 50 条

[1] Novel N9-arenethenyl purines as potent dual Src/Abl tyrosine kinase inhibitors
Wang, Yihan
Shakespeare, William C.
Huang, Wei-Sheng
Sundaramoorthi, Raji
Lentini, Scott
Das, Sasmita
Liu, Shuangying
Banda, Geeta
Wen, David
Zhu, Xiaotian
Xu, Qihong
Keats, Jeffrey
Wang, Frank
Wardwell, Scott
Ning, Yaoyu
Snodgrass, Joseph T.
Broudy, Mark I.
Russian, Karin
Dalgarno, David
Clackson, Tim
Sawyer, Tomi K.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (17) : 4907 - 4912
[2] Discovery of novel purine derivatives with potent and selective inhibitory activity against c-Src tyrosine kinase
Huang, He
Ma, Jingui
Shi, Jianmei
Meng, Linghua
Jiang, Hualiang
Ding, Jian
Liu, Hong
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (13) : 4615 - 4624
[3] 6, 9-Disubstituted purines as potent dual Src/Abl tyrosine kinase inhibitors targeting the "inactive" conformation
Huang, Wei-Sheng
Zhu, Xiaotian
Wang, Yihan
Azam, Mohammad
Wen, David
Sundaramoorthi, Raji
Thomas, R. Mathew
Liu, Shuangying
Banda, Geeta
Lentini, Scott
Das, Sasmita
Xu, Qihong
Keats, Jeff
Wang, Frank
Wardwell, Scott
Ning, Yaoyu
Snodgrass, Joseph T.
Broudy, Mark I.
Russian, Karin
Iuliucci, John
Dalgarno, David C.
Clackson, Timothy P.
Daley, George Q.
Sawyer, Tomi K.
Shakespeare, William C.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
[4] Purine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors for autoimmune diseases
Shi, Qing
Tebben, Andrew
Dyckman, Alaric J.
Li, Hedy
Liu, Chunjian
Lin, James
Spergel, Steve
Burke, James R.
McIntyre, Kim W.
Olini, Gilbert C.
Strnad, Joann
Surti, Neha
Muckelbauer, Jodi K.
Chang, Chiehying
An, Yongmi
Cheng, Lin
Ruan, Qian
Leftheris, Katerina
Carter, Percy H.
Tino, Joseph
De Lucca, George V.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (09) : 2206 - 2211
[5] SYNTHESIS OF NOVEL OXINDOLE DERIVATIVES AS INHIBITORS OF C-SRC TYROSINE KINASE
Kurt, Z. K.
Olgen, S.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 44 : 189 - 190
[6] Last Findings on Dual Inhibitors of Abl and Src Tyrosine-Kinases
Schenone, S.
Manetti, F.
Botta, M.
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (02) : 191 - 201
[7] MEDI 23-Design and synthesis of quinazoline derivatives as novel, potent multiacting HDAC and receptor tyrosine kinase inhibitors for the treatment of cancer
Cai, Xiong
Zhai, Hai-Xiao
Lai, Cheng-June
Bao, Rudi
Qian, Changgeng
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 235
[8] Novel dual Src/Abl inhibitors for hematologic and solid malignancies
Schenone, Silvia
Brullo, Chiara
Musumeci, Francesca
Botta, Maurizio
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (08) : 931 - 945
[9] Novel Src/ Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/ Abl signaling
Bieerkehazhi, Shayahati
Chen, Zhenghu
Zhao, Yanling
Yu, Yang
Zhang, Huiyuan
Vasudevan, Sanjeev A.
Woodfield, Sarah E.
Tao, Ling
Yi, Joanna S.
Muscal, Jodi A.
Pang, Jonathan C.
Guan, Shan
Zhang, Hong
Nuchtern, Jed G.
Li, Hui
Li, Huiwu
Yang, Jianhua
ONCOTARGET, 2017, 8 (01) : 1469 - 1480
[10] Synthesis and Anticancer Activity of Novel Indole Derivatives as Dual EGFR/SRC Kinase Inhibitors
Olgen, Sureyya
Kaleli, Sevde Nur Biltekin
Karaca, Banu Taktak
Demirel, Ural U.
Bristow, Hacer Karatas
CURRENT MEDICINAL CHEMISTRY, 2024, 31 (24) : 3798 - 3817

← 1 2 3 4 5 →